Biodexa Pharmaceuticals
BDRX | NASDAQ
$2.80
-$0.63 (-18.37%)
At close: Nov 2, 2026, 4:00 PM ET
$2.98
+$0.18 (+6.43%)
After-hours:
Nov 2, 2026, 5:04 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.88M | -2.56M | -3.81M | -2.42M | -3.31M | -3.51M | -3.57M | -4.6M | -3.06M | -2.31M | -3.15M |
Depreciation & Amortization | 80.59K | 48.7K | 140.61K | 116.21K | 136K | 144.22K | 142.63K | 170.93K | 179.75K | 225.92K | 179.87K |
Stock-Based Compensation | n/a | n/a | 97K | 133K | 150K | 13K | 15K | 23K | 100K | 52K | 37K |
Other Working Capital | n/a | n/a | n/a | 2.24M | n/a | n/a | -207K | 165K | -8K | n/a | n/a |
Other Non-Cash Items | -2.25M | -1.56M | -1.78M | -2.85M | -487K | 146.78K | -248.63K | 750.07K | -649.75K | -819.92K | -133.87K |
Deferred Income Tax | n/a | n/a | n/a | -250K | n/a | n/a | -118K | -254K | 124K | -424K | 822K |
Change in Working Capital | -563.1K | 1.75M | 2.05M | -2.44M | -1.3M | 262K | -104K | 396K | -232K | 372K | -859K |
Operating Cash Flow | -4.62M | -2.33M | -3.3M | -7.71M | -4.81M | -2.95M | -3.88M | -3.51M | -3.54M | -2.9M | -3.11M |
Capital Expenditures | -7.14K | -60.86 | -2K | -774K | -4 | -22K | -4K | -29K | -33K | -131K | -189K |
Cash Acquisitions | n/a | 17.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -351.48K | 71.74K | 97.31K | -263K | 24K | -174K | 16K | 0.60 | 42K |
Investing Cash Flow | -734.48K | -308.93K | -353.48K | 62.74K | -754K | -285K | 20K | -203K | -17K | -131K | -147K |
Debt Repayment | n/a | -447.23K | -95K | 245K | -93K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -63.25K | -22.18K | -123.33K | -4.43M | 3.83K | 3.97M | 6.25M | 125K | -78K | 8.89M | -81K |
Financial Cash Flow | -63.25K | 7.18M | 5.69M | 4.13M | 4.65M | 3.97M | 6.25M | 125K | -78K | 8.89M | -81K |
Net Cash Flow | -5.45M | 4.41M | 4.04M | -3.44M | 5.06M | 372K | 1.2M | -1.79M | 6.42M | 2.93M | -1.67M |
Free Cash Flow | -4.62M | -2.33M | -3.31M | -8.23M | -4.81M | -2.97M | -3.89M | -3.54M | -3.57M | -3.03M | -3.3M |
Adj. Free Cash Flow | -4.62M | -2.33M | -3.4M | -8.36M | -4.96M | -2.98M | -3.9M | -3.56M | -3.67M | -3.08M | -3.33M |
Maintenance CapEx | -7.14K | -60.86 | -2K | -774K | -4 | -22K | -4K | n/a | n/a | -127.37K | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -29K | -33K | -3.63K | -189K |
Owner Earnings | -4.62M | -2.33M | -3.31M | -8.23M | -4.81M | -2.97M | -3.89M | -3.51M | -3.54M | -3.03M | -3.11M |
Add to Watchlist
Select watchlists to add or remove BDRX